Global tuberculosis rates remain high as experts call for innovation
Approximately 10.7 million people were diagnosed with tuberculosis in 2024, resulting in 1.23 million deaths.

Global tuberculosis rates remain high, prompting calls for new prevention strategies and better healthcare access.
The World Health Organization states that tuberculosis continues to pose a significant global health challenge. In 2024, approximately 10.7 million individuals were diagnosed with the disease, and 1.23 million fatalities were attributed to it.
Dr Ludoviko Zirimenya, a former palliative care physician, noted that many patients suffering from advanced disease were also living with HIV, which complicated treatment and recovery. He stated that tuberculosis must be treated as a social issue as well as a medical one by examining intersecting factors that contribute to its persistence.
The inadequacy of current vaccination efforts contributes to the persistence of the disease. The BCG vaccine, which was developed over 100 years ago, is still the most widely used vaccination, but its effectiveness varies based on demographic and geographic factors.
Experts are calling for innovative strategies tailored to modern epidemiological data. Research is ongoing into next-generation tuberculosis vaccines, with a focus on the unique challenges in low and middle-income countries.
Addressing the disease requires improved medical interventions and enhanced healthcare systems. Strengthening health infrastructure is necessary to improve access to diagnosis, treatment, and preventive measures.
Key facts
- In 2024, 10.7 million people were diagnosed with tuberculosis and 1.23 million died from the disease.
- The BCG vaccine remains the most widely used tuberculosis vaccine despite being over 100 years old.
- Research is currently focused on developing next-generation vaccines for different populations, particularly in low and middle-income countries.
Three perspectives
Neutral
Tuberculosis remains a significant global health challenge with high diagnosis and fatality rates.
Positive
Researchers are working on next-generation vaccines and innovative strategies to reduce the burden of the disease.
Negative
The effectiveness of the century-old BCG vaccine varies significantly, leaving many individuals vulnerable.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.